A comparison of two- and three-dose MVA-BN mpox vaccination series on anti-monkeypox virus immunity

Abstract The 2022 global outbreak of clade IIb mpox represented a turning point in public health’s handling of poxviruses. The primary vaccine available for the prevention of mpox is modified vaccinia Ankara from Bavarian-Nordic (MVA-BN). We previously reported a nondurable and low-avidity antibody...

Fuld beskrivelse

Bibliografiske detaljer

Principais autores:	Aaron L. Oom, Kesi K. Wilson, Stephanie Rettig, Michael Tuen, Marie I. Samanovic, Angelica C. Kottkamp, Ramin Sedaghat Herati, Ralf Duerr, Mark J. Mulligan, On behalf of the NYC OSMI Study Group
Format:	Artigo
Sprog:	Inglês
Udgivet:	Nature Portfolio 2026-05-01
Serier:	npj Vaccines
Online adgang:	https://doi.org/10.1038/s41541-026-01475-z
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!